Rongta Tech faces HKEX resumption guidance; share trading remains halted since 1 April 2026

Bulletin Express
04/27

Rongta Technology (Xiamen) Group Co., Ltd. (Rongta Tech) has received a formal resumption roadmap from The Stock Exchange of Hong Kong after trading in its H-shares was suspended on 1 April 2026 due to delayed publication of FY2025 results.

Key directives from HKEX, issued on 24 April 2026, require Rongta Tech to:

• Complete an independent forensic investigation into transactions linked to the audit issues, disclose findings, and implement remedial measures. • Verify that management integrity, competence and character satisfy regulatory expectations. • Engage an independent consultant to review and rectify internal‐control deficiencies, and demonstrate that the control environment enables full Listing Rule compliance—particularly in financial reporting and related-party transactions. • Publish all outstanding financial statements and resolve any audit qualifications. • Prove ongoing compliance with Listing Rule 13.24 regarding sufficient operations or assets. • Release all material information needed for investors to assess the company’s position.

Timeline pressure is significant. Under Listing Rule 6.01A(1), HKEX may cancel Rongta Tech’s listing if suspension exceeds 18 months; the deadline falls on 30 September 2027. The exchange retains the discretion to impose a shorter remedial period.

Operationally, Yue Xiu Capital Limited—appointed on 10 June 2025 as the company’s compliance adviser—must be proactively involved throughout the remediation process. In addition, Rongta Tech must issue quarterly progress updates; the first is due by 30 June 2026.

Share trading will remain frozen until audited FY2025 results are released. The board, chaired by Mr. Xu Kaiming, advises shareholders and prospective investors to exercise caution while the suspension persists.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10